Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Samonigg Hellmut |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Domke, A; Jahn-Kuch, D; Bitsche, S; Posch, N; Berghold, A; Samonigg, H; Avian, A; Jeitler, K; Siebenhofer, A
End-of-Life care in Austria - a postal survey of General Practitioners, Hemato-Oncologists and Internists.
23rd WONCA Europe Conference – Family Medicine: Quality. Efficiency. Equity.; MAY 24-27, 2018; Kraków, POLAND. 2018.
[Oral Communication]
FullText
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M
Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
ÖGHO; March 17-19, 2016; Wien. 2016.
[Oral Communication]
Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Gerger, A; Stotz, M;
23 Risk stratification for venous thromboembolism in patients with testicular germ cell tumours
European Urology Supplements. 2016; 15(3):E23--European Association of Urology (EAU) Annual Meeting; MAR 11-15, 2016; Munich, GERMANY.
[Oral Communication]
FullText
Posch, F; Liegl-Atzwanger, B; Thalhammer, M; Stotz, M; Bezan, A; Mrsic, E; Samonigg, H; Pichler, M; Gerger, A; Szkandera, J
Local recurrence, distant metastasis, adjuvant imatinib, and long-term survival outcomes in patients with gastrointestinal-stroma-tumors (GIST) after curative surgery: A multi-state model
ÖGHO; MARCH, 17-19, 2016; WIEN. 2016.
[Oral Communication]
Smolle, MA; Pichler, M; Roßmann, C; Samonigg, H; Heitzer, E; Belic, J; Speicher, M; Pummer, K; Bauernhofer, T
Neuroendocrine transdifferentiation in castration resistant metastatic prostate cancer (mCRPC) - A case series
OeGHO & AHOP Frühjahrstagung; MAR 17 - 19, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Viertler, C; Stadelmeyer, E; Al-Zoughbi, W; Kashofer, K; Schauer, S; Fackelmann, U; Bauernhofer, T; Samonigg, H; Jahn-Kuch, D; Schüler, J; Zühlsdorf, M; Höfler, G
MR-PDX models for the evaluation of cancer therapies
CBmed Biomarker Conference; FEB 11, 2016; Graz, AUSTRIA. 2016.
[Poster]
Hofmann, G; Bitsche, S; Jahn-Kuch, D; Edelsbrunner, M; Pachmajer, J; Hild, R; Gusel, S; Samonigg, H
The Feasibility and Usefulness of the EAPC Basic Dataset in clinical Practice - a single Unit Experience.
European Journal of Palliative Care. 2015; 22(S1):191-191.-14th World Congress of the European Association for Palliative Care; MAY 8-10, 2015; Copenhagen, DENMARK.
[Poster]
Ress, Anna Lena; Stiegelbauer, Verena; Schwarzenbacher, Daniela; Deutsch, Alexander; Ling,Hui; Calin, George; Rinner, Beate; Gerger, Armin; Samonigg, Hellmut; Pichler, Martin.
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
. 2015; -Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25.04; Salzburg.
[Poster]
Stotz, M; Herzog, SA; Pichler, M; Szkandera, J; Schaberl-Moser, R; Samonigg, H; Renner, W; Berghold, A; Gerger, A;
Cancer stem cell gene variants and colon cancer prognosis.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 23-25, 2015; Salzburg. 2015.
[Poster]
Bezan, A; Hutterer, G; Stöckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M;
Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma partients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Bezan, A; Hutterer, G; Stöckigt, C; Stojakovic, T; Samonigg, H; Pummer, K; Zigeuner, R; Pichler, M;
High pre-operative monocyte-lymphocyte ratio (MLR) as a prognostic factor in non-metastatic clear cell renal cell carcinoma
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Bezan, A; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M;
A large scale validation study proposes high pre-operative plasma fibrinogen levels as an independent negative prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma patients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Eisner, F; Suppan, C; Kasparek, AK; Samonigg, H; Höfler, G; Zigeuner, R; Bauernhofer, T
Partielle Remission unter Therapie mit Everolimus bei 51jähriger Patientin mit Lymphangioleiomyomatose.
ÖGHO Frühjahrstagung ; APR 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Poster]
Fitzal, F; Filipits, MF; Rudas, M; Greil, R; Dietze, O; Samonigg, H; Lax, S; Herz, W; Bartsch, R; Leitner, G; Gnant, M;
Tailoring local therapy in post-menopausal endocrine responsive HER2neu negative breast cancer patients based on their genetic risk profile using Endopredict.
EUR J CANCER. 2014; 50: S97-S97.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
Web of Science
Hofmann, G; Klammer, M; Jahn-Kuch, D; Bitsche, S; Edelsbrunner, M; Verebes, J; Siegl, A; Kuba, S; Sandner-Kiesling, A; Samonigg, H
Outcome Quality of Pain Management on a Palliatve Care Unit as a Result of a Certification Process
Palliative Medicine. 2014; 28(6):862-862.-8 th World Research Congress of the European Association for Palliative Care (EAPC); JUNE 5-7, 2014; Lleida, SPAIN.
[Poster]
Stotz, M; Pichler, M; Bezan, A; Peinsith, H; Szkandera, J; Arminger, F; Schaberl-Moser, R; Samonigg, H; Stojakovic, T; Gerger, A
The preoperative C-reactive protein (CRP) and fibrinogen level predicts clinical outcome in patients with stage III colon cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014.
[Poster]
Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014.
[Poster]
Stotz, M; Szkandera, J; Stojakovic, T; Samonigg, H; Kornprat, P; Ress, AL; Seggewies, F; Gerger, A; Pichler, M
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 10-12, 2014; Innsbruck. 2014.
[Poster]
Suppan, C; Bjelic-Radisic, V; La Garde, M; Samonigg, H; Dandachi, N; Balic, M
N/L Ratio does not have predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
EUR J CANCER. 2014; 50: S193-S193.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
[Poster]
Web of Science
Suppan, C; Milkovic, L; Gasparovic, AC; Samonigg, H; Dandachi, N; Balic, M
Higher levels of HNE are associated with disease aggressiveness and worse outcome in breast cancer patients
EUR J CANCER. 2014; 50: S70-S70.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
[Poster]
Web of Science
Suppan, C; Steger, G; Balic, M; Dandachi, N; Lang, A; Mlineritsch, B; Fesl,C; Samonigg, H; Gnat,M; Bauernhofer,T;
Evaluation of soluble E-Cadherin as a predictive marker for response to preoperative systemic chemotherapy in early breast cancer
Annals of Oncology Supplement 2014. 2014; -IMPAKT; May 7-10, 2014; Brussels, Belgium.
[Poster]
Andritsch, E; Farkas, C; Zloklikovits, S; Samonigg, H
Hope and Meaning in the Context of Different Psychological Intervention Settings: When to Whom - How?.
PSYCHO-ONCOL. 2013; 22: 175-175.-15th World Congress of Psychooncology
Innovation in Psychooncology, clinical care- research- advocacy ; NOV 4-8, 2013; Rotterdam, Netherlands.
[Poster]
Web of Science
Andritsch, E; Farkas, C; Zloklikovits,S; Samonigg, H;Bauernhofer,T
Hope and Optimism - The Additional Benefit for Patients With Cancer in the Interdisciplinary Treatment - From the Perspective of Psychoneuroimmunology.
PSYCHO-ONCOL. 2013; 22: 175-176.-15th World Congress of Psychooncology, Innovation in Psychooncology, clinical care- research-advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
[Poster]
Web of Science
Brunner, C; Jaeger, T; Suppan, C; Mueller-Holzner, E; Jasarevic, Z; Balic, M; Goebel, G; Marth, C; Stoeger, H; Samonigg, H; Hubalek,M; Lang, A;
Cardiac safety and efficacy of concomitant liposomal doxorubicin, docetaxel, and trastuzumab as neoadjuvant therapy in HER2-overexpressing breast cancer: A retrospective analysis
ASCO 2013 Annual Meeting; MAY 31-JUNE 4, 2013; Chicago, USA. 2013.
[Poster]
Farkas, C; Ladinek, V; Zloklikovits, S; Samonigg, H; Andritsch, E
Effects of psycho-social variables on compliance and adherence in patients with cancer: A literature overview and preliminary data of a study relating antiemetic therapy during chemotherapy in a sample of patients treated at the Division of Oncology, Graz
ONKOLOGIE. 2013; 36: 109-109.
[Oral Communication]
Web of Science
Heitzer E, Mach M, Filipits M, Balic M, Resel M, Graf R, Weißenbacher B, Lax S, Heitzer, E; Mach, M; Filipits, M; Balic, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Samonigg, H; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Schaberl-Moser, R; Dandachi, N.
Methylation of PCDH10, SPARC, and UCHL1 predicts survival and in stage II colorectal cancer patients.
http://gfhev.de/de/kongress/GfH_Tagung_2013_Abstractbook.pdf. 2013; -24. Jahrestagung der Deutschen Gesellschaft für Humangenetik ; MAR 20-22,2013; Dresden, GERMANY.
[Poster]
Hofmann, G; Bitsche, S; Verebes, J; Stotz, M; Siegl, A; Kuba, S; Trattner, J; Sandner-Kiesling, A; Samonigg, H
Possible improvement of earlier detection and pain control on a palliative care unit by standardized protocols in the context of a certification process
European Journal of Palliative Care; EAPC 2013 Abstracts. 2013; 1(1):167-167.-13th World Congress of the European Association of Palliative Care; MAY 30 - JUNE 2, 2013; Prague, CZECH REPUBLIC.
[Poster]
Hofmann, G; Bitsche, S; Verebes, J; Stotz, M; Jahn-Kuch, D; Siegl, A; Kuba, S; Trattner, J; Sandner-Kiesling, A; Samonigg, H.
Mögliche Verbesserung der Früherkennung von Schmerz und schnellerer Schmerzkontrolle durch Einführen von standardisierten Abläufen im Rahmen eines Zertifizierungsverfahrens.
4. Österreichischer Interdisziplinärer Palliativkongress, Abstractband. 2013; 1(1):18-18.-4. Österreichischer Interdisziplinärer Palliativkongress; APR 18-20, 2013; Gmunden, AUSTRIA.
[Poster]
Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Kielhauser, S; Gerger, A; Absenger, G; Glehr, M; Szkandera, J; Samonigg, H; Krippl, P; Renner, W
Association of a common single nucleotide polymorphism in the TRAIL-R1 gene with relapse-free survival in rectal cancer patients.
Annals of Oncology. 2013; 24, Suppl. 4: iv51-iv52.-ESMO 15th World Congress on Gastrointestinal Cancer; JULY, 3-6, 2013; Barcelona, SPAIN. (ISBN: 0923-7534 )
[Poster]
Ress, AL; Aigelsreiter, A; Schauer, S; Eisner, F; Samonigg, H; Lackner, C; Haybaeck, J; Bauernhofer, T; Pichler, M
Correlation of loss of spinophilin expression with increased proliferation and viability as a prognostic factor in patients with hepatocellular carcinoma.
2013 ASCO Annual Meeting; Mai 31- Juni 4, 2013; Chicago. 2013.
Schnidar, H; Partl, R; Neubauer, A; Thurner, EM; Krenn-Pilko, S; Stranz, B; Groiss, F; Schuster, M; Samonigg, H; Kapp, KS; Loibner, H
Clinical phase 1b testing of liposomal recombinant human Superoxid Dismutase (APN201) to prevent radiation-induced dermatitis in female breast cancer patients
VII Moscow International Congress
Biotechnology: State of the Art and Prospects of Development
; March 19-22, 2013; Moscow, RUSSIA. 2013.
[Oral Communication]
Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg, H; Stojakovic, T; Gerger, A; Leithner, A
Elevated preoperative neutrophil/lymphocyte ratio is associated
with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; PSR:110. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN.
[Oral Communication]
Szkandera, J; Absenger, G; Liegl-Atzwanger, B; Pichler, M; Zacherl, M; Samonigg; H; Stojakovic, T; Gerger, A; Leithner, A
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients.
Abstracts of 26th EMSOS; P6:101. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN.
[Poster]
Szkandera, J; Gerger, A; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Samonigg, H; Maurer-Ertl, W; Stojakovic, T; Ploner, F; Leithner, A; Pichler, M
VALIDATION OF THE PROGNOSTIC RELEVANCE OF PLASMA C-REACTIVE PROTEIN LEVELS IN SOFT TISSUE SARCOMA.
Abstracts of the 18th Annual Meeting CTOS, P 94. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA.
[Poster]
Szkandera, J; Pichler, M; Liegl-Atzwanger, B; Absenger, G; Stotz, M; Ploner, F; Stojakovic, T; Samonigg, H; Leithner, A; Gerger, A
THE ELEVATED PRE-OPERATIVE PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR FOR CANCER-SPECIFIC; METASTASIS-FREE AND OVERALL SURVIVAL IN SOFT-TISSUE SARCOMA PATIENTS.
Abstracts of the 18th Annual Meeting CTOS, P 93. 2013; -Connective Tissue Oncology Society 18th Annual Meeting; OCT 30 - NOV 2, 2013; New York, USA.
[Poster]
Walter, E; Said, M; Bauer, M; Gastl, G; Samonigg, H
COST OF CANCER IN THE AUSTRIAN HOSPITAL SETTING
VALUE HEALTH. 2013; 16(7): A407-A407.
Doi: 10.1016/j.jval.2013.08.485
[Poster]
Web of Science
FullText
FullText_MUG
Winder, T; Szkandera, J; Absenger, G; Weismüller, M; Pichler, M; Stotz, M; Lax, S; Leitner, G; Asslaber, M; Renner, W; Samonigg, H; Gerger, A
A functional germline variant in Hedgheog pathway gene GLI1 identifies patients at high risk of tumor recurrence in stage II and III colon cancer
http://worldgicancer.com/WCGI/WGIC2013/. 2013; -World Congress on Gastrointestinal Cancer; July 3-6, 2013; Barcelona, Spain.
[Oral Communication]
Absenger, G; Szkandera, J; Weissmuller, M; Postlmayr, U; Pichler, M; Loibner, H; Samonigg, HS; Gerger, A;
The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer.
ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER;
[Poster]
Web of Science
Eisner, F; Pichler, M; Gerger, A; Schaberl-Moser, R; Samonigg, H
49 Monate Progressions-freies Überleben bei einem Patienten mit metastasiertem Kolonkarzinom unter Avastin- Erhaltungstherapie Ein Fallbericht
Frühjahrstagung der Österreichischen Gesellschaft für Hämtologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Eisner, F; Schaberl-Moser, R; Pichler, M; Samonigg, H
The multi-kinase inhibitor sorafenib in metastatic follicular thyroid cancer a case report
Frühjahrstagung der Österreichischen Gesellschaft für Hämatlogie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Eisner, F; Stotz, M; Samonigg, H; Lax, S; Hoefler, G; Pichler, M
Down-regulation of KRAS-interacting miRNA-143 to predict prognosis and response to EGFR-targeted agents in colorectal cancer.
ASCO Annual Meeting 2012; JUN 1-5, 2012; Chicago, USA. 2012.
FullText
Gary, T; Belaj, K; Steidl, K; Pichler, M; Eisner, F; Hafner, F; Froehlich, H; Samonigg, H; Pilger, E; Brodmann, M
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY.
Doi: 10.1016/S0049-3848(12)70103-2
[Oral Communication]
Web of Science
FullText
FullText_MUG
Gary, T; Belaj, K; Steidl, K; Pichler,M; Eisner, F; Stoeger,H; Hafner, F; Froehlich,H; Samonigg, H; Pilger,E; Brodmann, M
Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival
1.Kongress des Verbandes für österreichische Gefäßmedizin (VASCMED); Oct 18-20, 2012; Graz. 2012.
[Oral Communication]
Hofmann, G; Bitsche, S; Osprian, I; Verebes, J; Greimel, A; Schippinger, W; Dandachi, N; Samonigg, H; Heitzer, E; EPCRC
Biomarkers as Possible Indicators for Pain Experience ansd Treatment Outcome.
Palliative Medicine. 2012; 26(4):428-429.-7th World Research Congress of the European Association for Palliative Care; JUNE 7-9, 2012; Trondheim, NORWAY.
[Oral Communication]
Hofmann, G; Geigl, JB; Kastner, N; Leithner, A; Bodo, K; Kielhauser, S; Samonigg, H; Gruber, G
Genomic variability in osteosarcomas and its association with different responses to neoadjuvant polychemotherapy.
MEMO . 2012; 5 Suppl.(1/12):24-24.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 12-14, 2012; Graz, AUSTRIA.
[Poster]
Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Absenger, G; Szkandera, J; Samonigg, H; Krippl, P; Renner, W;
COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS.
ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Moazedi-Fuerst, F; Gerger, A; Kielhauser, S; Thurner, E-M; Absenger, G; Szkandera, J; Samonigg, H; Glehr, M; Krippl, P; Renner, W
Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients.
Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY.
[Poster]
Web of Science
Kapp, KS; Hauser, H; Regitnig, P; Samonigg, H; Berghold, A
Interdisziplinär kommentiert
5. Radioonkologisches Seminar 2012; JUN 22-23; Eckberg/Gamlitz, AUSTRIA. 2012.
[Oral Communication]
Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T;
Blood-based treatment monitoring of metastatic colorectal
cancer patients by KRAS mutation analysis
Frühjahrstagung der österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2012; Graz. 2012.
[Poster]
Maritschnegg, E; Dandachi, N; Stadelmeyer, E;, Speicher, MR; Heitzer, E; Samonigg, H; Höfler, G; Pichler, M; Otte, M; Bauernhofer, T;
KRAS mutation analysis using blood derived cell free tumor DNA for treatment monitoring of metastatic colorectal cancer patients
Cancer Res., . 2012; 72: 4513. : -AACR Annual Meeting; MAR 31- APR 4, 2012; Chicago, USA.
[Poster]
Pichler, M; Doleschal, B; Groschner, K; Maechler, H; Bauernhofer, T; Kass, D; Pieske, B; von Lewinski, D; Samonigg, H; Rainer, P
Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes
Frühjahrstagung der Österreichischen Gesellschaft für Hämatolologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Hutterer, G; Chromecki, T; Samonigg, H; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Validation of the 2002 and 2010 TNM classification systems for the prediction of metastasis-free and overall survival in renal cell carcinoma patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Hutterer, G; Chromecki, T; Samonigg, H; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R
Renal cell carcinoma stage migration in a single European center over 25 years: effects on 5 and 10 years metastasis-free survival
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Pichler, M; Winter, E; Bauernhofer, T; Lax, S; Samonigg, H; Hoefler, G
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012.
[Poster]
Szkandera, J; Absenger, G; Dandachi, N; Regitnig, P; Lax, S; Stotz, M; Winder, T; Samonigg, H; Renner, W; Gerger, A
Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
[Poster]
Web of Science
Szkandera, J; Absenger, G; Stotz, M; Weissmuller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
[Poster]
Web of Science
Szkandera, J; Winder, T; Absenger, G; Stotz, M; Weissmuller, M; Langsenlehner, T; Hofmann, G; Samonigg, H; Renner, W; Gerger, A;
A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN.
ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
[Poster]
Web of Science
Szkandera, J; Zulus, B; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A
The functional rs1617640 polymorphism in the promoter of the erythropoietin gene is not associated with susceptibility and outcome of early-stage breast cancer.
Drug Metabolism and Drug Interactions. 2012; 27(3):22-22.-6th Santorini Conference Biologie Prospective.; SEP 30-OKT 2, 2012; Thira, GREECE.
[Poster]
Doleschal, B; Rainer, PP; Saad, Z; Groschner, K; Mächler, H; Höfler, G; Samonigg, H; Pieske, B; von Lewinski, D; Pichler; M
Der Multikinaseinhibitor Sunitinib hat akute Auswirkungen auf die kardiale Kontraktilität
J f Kardiologie. 2011; -Annual Session of the Austrian Society for Cardiology; MAY 25-28, 2011; Salzburg.
[Poster]
Doleschal, B; Rainer, PP; Saad, Z; Groschner, Maechler, H; K; Hoefler, G; Samonigg; Pieske, BM; von Lewinski, D; Pichler, M;
Acute effects of the targeted anti-cancer agent sunitinib on cardiac contractility
European Heart Journal. 2011; 32(1):294--ESC Congress; Aug 27-31, 2011; Paris, Austria.
[Poster]
Eichmann, E; Eisner, F; Stojakovic, T; Kiesslich, T; Lackner, C; Bauernhofer, T; Mischinger, H; Samonigg, H; Pichler, M
Prognostic value of commonly measured laboratory parameters in
patients with biliary malignancies.
EUROPEAN SURGERY Acta Chirurgica Austriaca . 2011; -52. Österreichischer Chirurgenkongress; JUN 23-25, 2011; Vienna, AUSTRIA.
[Poster]
Hofmann, G; Bitsche, S; Osprian, I; Verebes, J; Greimel, A; Schippinger, W; Dandachi, N; Samonigg, H; Heitzer, E
Biomarkers as indicators for pain perception and treatment response
3. Österreichischer interdisziplinärer Palliativkongress; DEC 8-10, 2011; Klagenfurt, AUSTRIA. 2011.
[Poster]
Hofmann, G; Geigl, JB; Kastner, N; Leithner, A; Koppany, B; Samonigg, H; Gruber, G
Genetic differences in preoperative specimen of osteosarcoma and their impact on response to neoadjuvant chemotherapy
ONKOLOGIE. 2011; 34: 251-252.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SCHWEIZ.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Bitsche, S; Absenger, G; Samonigg, H; Krippl, P; Renner, W
RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS IS NOT ASSOCIATED WITH SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRIN RECEPTOR SUBUNITS
ANN ONCOL. 2011; 22: v109-v109.-ESMO 13th World Congress on Gastrointestinal Cancer ; JUN 22-25, 2011; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W
A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS
ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Absenger, G; Samonigg, H; Krippl, P; Renner, W
Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients
ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND.
[Poster]
Web of Science
Loibner, H; Poglitsch, M; Schwager, C; Stranner, S; Janzek ,E; Schuster, M; Bauernhofer, T; Samonigg, H
Cancer and the renin angiotensin system (RAS): Substantial activation as evidenced by quantification of various RAS peptides and their metabolites in plasma by LC-MS
J Clin Oncol 29; supp ( abstr e21171)
2011; -ASCO Annual Meeting; JUN 3-7, 2011; Chicago, IL, USA.
FullText
Aigelsreiter, A; Osprian, I; Sauseng, S; Lackner, C; Samonigg, H; Mischinger, HJ; Pichler, M
Trends in overall and disease-free survival after curative hepatic resection for hepatocellular carcinoma
51. Chirurgenkongress; JUN 2-4, 2010; Linz, AUSTRIA. 2010.
[Poster]
Aigelsreiter, A; Osprian, I; Sauseng, S; Lackner, C; Samonigg, H; Mischinger, HJ; Pichler, M
Liver resection for hepatocellular carcinoma in cirrhotics and non-cirrhotics: evaluation and comparison of long-term and recurrence-free survival
51. Chirurgenkongress; JUN 2-4, 2010; Linz, AUSTRIA. 2010.
[Poster]
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W
COMMON VEGF RECEPTOR GENE POLYMORPHISMS AND THEIR INFLUENCE ON OVERALL SURVIVAL IN COLORECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):35-35.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Knechtel, G; Samonigg, H; Krippl, P; Renner, W
ASSOCIATION OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRINS WITH METASTASIS-FREE SURVIVAL IN RECTAL CANCER PATIENTS
Annals of Oncology2010; 21(S 6):59-59.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN.
[Poster]
Web of Science
Karl, W; Fahrleitner-Pammer, A; Dandachi, N; Strutz, J; Rapp, N; Pieber, TH; Samonigg, H; Balic, M
Breast cancer stem cells and their responsiveness to zoledronic acid and anti-RANKL antibody
www.oegekm.at2010; -Wissenschaftliche Herbsttagung der Ögekm ; 26. - 27. November 2010; Vienna.
[Poster]
Knechtel, G; Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Dehchamani, D; Gerger, A
Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 )
[Oral Communication]
Web of Science
Knechtel, G; 1, Szkandera, J; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Samonigg, H; Renner, W; Langner, C; Dehchamani, D; Gerger, A;
Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk
MEMO Suppl 01/10; 2010; 16-17.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA.
[Poster]
Osprian, I; Pichler, M; Samonigg, H; Ploner, F; Bauernhofer, T;
Third line treatment of relapsed small-cell lung cancer with irinotecan and carboplatin: A case report.
ÖGHO Frühjahrstagung 2010; APRIL 8-10, 2010; Bregenz, Austria. 2010.
[Poster]
Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A
Assiciation of hypoxia inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.
MEMO Suppl 01/10; 2010; 16-16.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz, AUSTRIA.
[Poster]
Szkandera, J; Knechtel, G; Stotz, M; Hofmann, G; Langsenlehner, U; Krippl, P; Langsenlehner, T; Dehchamani, D; Samonigg, H; Renner, W; Gerger, A
Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis.
Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 )
[Oral Communication]
Web of Science
Szkandera, J; Ploner, F; Bauernhofer, T; Kasparek, AK; Payer, F; Balic, M; Knechtel, G; Gerger, A; Galle; Samonigg, H; Hofmann, g;
Paraneoplastic limbic encephalitis in a patient with extragonadal chorioncarcinoma - the significance of onconeural antibodies: a case report
MEMO Suppl 01/10; 2010; 20-21.-Frühjahrstagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10; Bregenz, AUSTRIA .
[Poster]
Zloklikovits, S; Augustin, T; Stanzer, S; Samonigg, H; Bauernhofer, T; Andritsch, E
Psychoeducational group intervention in patients with early breast cancer: is there a waiting group effect?
Psycho-Oncology 2010; 19(Sup2):S281--12th IPOS World Congress of Psycho-Oncology; MAY 25-29, 2010; Quebec City, CANADA.
[Poster]
Balic, M; Rapp, N; Strutz, J; Lin, H; Stanzer, S; Skandera, J; Samonigg, H; Cote, RJ; Dandachi, N
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells
7th International Symposium on Minimal Residual Cancer; SEP 16-19, 2009; Athens, Greece. 2009.
[Poster]
FullText
Chan, A; Vanlemmens, L; Conte, PF; Beith, J; Samonigg, H; Verma, S; Srimuninnimit, V; Martoni, A; Miles, DW
Efficacy of bevacizumab (BV) plus docetaxel (D) does not correlate with hypertension (HTN) or G-CSF use in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) in the AVAIDO phase III study
CANCER RES. 2009; 69(2):114S-114S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX.
[Poster]
Web of Science
Eisner, F; Schippinger, W; Samonigg, H
Impact of therapy with octreotide and butylscopolamine on frequency of emesis in malignant chronic bowel obstruction
11th EAPC Congress, Vienna. 2009; -EAPC; MAY 7-10, 2009; Vienna, AUSTRIA.
[Poster]
Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Knechtel, G; Szkandera, J; Samonigg, H; Krippl, P; Langselnlehner, U
Association of Interleukin-10 gene variation wit breast cancer prognosis
Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 14-16, 2009; Salzburg. 2009.
[Poster]
Goetz, M; Ames, M; Gnant, M; Filpits, M; Jakesz, R; Greil, R; Marth, C; Samonigg, H; Suman, V; Safgren, S; Kuffel, M; Weinshilboum, R; Erlander, M; Ma, XJ; Ingle, J
Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.
CANCER RES. 2009; 69(2):77S-77S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX.
[Keynote lecture]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
A hereditary single nucleotide polymorphism in the FAS gene and its impact on developing metastases in rectal cancer patients.
Annals of Oncology. 2009; 20(S 7):58-58.-11th World Congress on Gastrointestinal Cancer ; JUNE 24-27; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
Genetic variants of integrin receptor genes are not associated with colorectal cancer survival
Onkologie2009; 32(S 4):75-75.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie ; OCT 2-6, 2009; Heidelberg/Mannheim, GERMANY.
[Oral Communication]
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
A common hereditary single nucleotide polymorphism in the FASL-gene and its impact on colorectal cancer survival.
Onkologie2009; 32(S 4):75-75.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg/Mannheim, GERMANY.
[Oral Communication]
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
The FASL -844T>C polymorphism is not associated with metastasis-free survival in patients with colorectal cancer
MEMO Suppl 02/09; 2009; 2: 21-22.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA.
[Poster]
Jakesz, R; Gnant, M; Griel, R; Tausch, C; Samonigg, H; Kwasny, W; Kubista, E; Stierer, M; Luschin, G; Ruecklinger, E; Mittlbock, M
Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8
CANCER RES. 2009; 69(2):67S-67S.-31st Annual San Antonio Breast Cancer Symposium; DEC 10-14, 2008; San Antonio, TX.
[Keynote lecture]
Web of Science
Knechtel, G; Gerger, A; Renner, W; Langsenlehner, T; Hofmann, G; Szkandera, J; Samonigg, H; Krippl, P; Langsenlehner, U
Analysis of common germline polymorphisms to predict metastasis in node-positive breast cancer
MEMO Suppl 02/09; 2009; 2: 20-21.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 16-18, 2009; Salzburg, AUSTRIA.
[Oral Communication]
Knechtel, G; Stoeger, H; Szkandera, J; Dorr, K; Beham, A; Samonigg, H
Desmoid tumor treated with polychemotherapy followed by Imatinib
A case report and a review of literature
MEMO Suppl 02/09; 2009; 2: 20-20.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie ; APRIL 14-16, 2009; Salzburg, AUSTRIA.
[Poster]
Ladinek, V; Zloklikovits, S; Stanzer, S; Augustin, T; Janesch, B; Bauernhofer, T; Samonigg, H; Andritsch, E
The Influence of an Educational Intervention Program on Patients with Early Breast Cancer on Depression and Anxiety.
Abstract book of the 11 th IPOS World Congress of Psycho-Oncology published in
Psycho-Oncology2009; 18 (Suppl. 2): S1-S330.-11th IPOS World Congress of Psycho-Oncology; JUNE 23-25, 2009; Vienna, AUSTRIA. (ISBN: DOI: 10.1002/pon.159 )
Doi: 10.1002/pon.159
[Poster]
FullText
FullText_MUG
Loibner, H; Janzek, E; Peball, B; Schaefer, R; Schustet, M; Bauernhofer, T; Samonigg, H
Elevated Angiotensin II Levels in Plasma and Malignant Effusions of Cancer Patients: Recombinant Human ACE2 as Novel Biological Cancer Therapy
J IMMUNOTHER. 2009; 32(9):952-952.
[Poster]
Web of Science
Osprian, I; Schippinger, W; Samonigg, H;
Prevalence of Anaemia in Cancer Patients Receiving Palliative Care
Abstract book of the 11th Congress of the EAPC
2009; -11th Congress of the European Association for Palliative Care; 7-10 May 2009 ; Vienna, Austria.
[Poster]
Pichler, M; Balic M; Stadelmeyer, E; Ausch, C; Wild, M; Guelly, C; Bauernhofer, T; Samonigg, H; Dandachi, N
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors
joint ZMF & Doctorial Day ; NOV 4-5, 2009; Graz, AUSTRIA. 2009.
[Oral Communication]
Pichler, M; Balic, M; Stadelmeyer, E; Ausch, C; Wild, M; Gülly C; Bauernhofer, T; Samonigg, H; Hoefler, G; Dandachi, N;
Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumours.
Frühjahrstagung 2009 der Österreichischen Gessellschaft für Hmatologie und Onkologie (ÖGHO); APR 16-18, 2009; Salzburg. 2009.
[Oral Communication]
Pichler, M; Samonigg, H; Bauernhofer, T;
Rhabdomyolysis as a complication of trabectedin (Yondelis) treatment in metastatic leiomyosarcoma: a case report.
Frühjahrstagung 2009 der Österreichischen gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 16-18, 2009; Salzburg, AUSTRIA. 2009.
[Poster]
Schippinger, W; Osprian, I; Eisner, F; Samonigg, H;
Chronic Renal Insufficiency in Palliative Care: Possible Impact on Drug Excretion.
Abstract book of the 11th Congress of the EAP2009; -11th Congress of the European Association for Palliative Care; 7-10 May 2009 ; Vienna, Austria.
[Poster]
Schippinger, W; Osprian, I; Spat, S; Pilgram, H; Baumgartner, J; Samonigg, H;
Economic effects of palliative care provided by a home care support team of a University hospital in Austria.
Abstract book of the 11th Congress of the EAPC2009; -11th Congress of the European Association for Palliative Care; 7-10 May 2009 ; Vienna, Austria.
[Poster]
Stanzer, S; Janesch, B; Andritsch, E; Ladinek, V; Zloklikovits, S; Augustin, T; Halm, M; Wagner, P; Samonigg, H; Bauernhofer, T;
Influence of Psychosocial Intervention on T Cell Subpopulations in Patients with Early Breast Cancer
Abstract Book of the 11th World Congress of Psycho-Oncology published in Psycho-Oncology2009; 18 (Suppl. 2): S1-S330.-IPOS 11th World Congress of Psycho-Oncology; JUN 23-25, 2009; Vienna, AUSTRIA. (ISBN: DOI: 10.1002/pon.159 )
Doi: 10.1002/pon.159
[Poster]
FullText
FullText_MUG
Stanzer, S; Janesch, B; Resel, M; Augustin, T; Samonigg, H; Bauernhofer, T
Relationship of oxidative stress products to the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer.
joint ZMF & Doctorial Day ; NOV 4-5 2009; Graz, AUSTRIA. 2009.
[Poster]
Stanzer, S; Janesch, B; Resel, M; Augustin, T; Samonigg, H; Bauernhofer, T
Relationship of oxidative stress products to the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer
5th Internation Symposium of Cellular Therapy; March 19-20 2009 ; Nürnberg, GERMANY. 2009.
[Poster]
Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Melbinger-Zeinitzer, E; Marth, C; Samonigg, H; Kubista, E; Gnant, M
Final Results of ABCSG-24, a Randomized Phase III Study Comparing Epirubicin, Docetaxel, and Capecitabine (EDC) to Epirubicin and Docetaxel (ED) as Neoadjuvant Treatment for Early Breast Cancer and Comparing ED/EDC plus Trastuzumab (T) to ED/EDC as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer
CANCER RES. 2009; 69(24):564S-564S.
[Poster]
Web of Science
Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Melbinger-Zeinitzer, E; Martin, C; Samonigg, H; Kubista, E; Gnant, M
A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer - first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)
EJC SUPPL. 2009; 7(3):3-3.
Doi: 10.1016/S1359-6349(09)72030-0
[Oral Communication]
Web of Science
FullText
FullText_MUG
Szkandera, J; Balic, M; Rapp, N; Strutz, J; Cote, RJ; Samonigg, H
Neue Methoden zum Nachweis und Charakterisierung vermeintlicher disseminierter Brustkrebsstammzellen.
MEMO Suppl 02/09; 2009; 2: 1-1.-Frühjahrstagung 2009 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 16-18, 2009; Salzburg, AUSTRIA.
[Oral Communication]
Andritsch, E; Zloklikovits, S; Ladinek, V; Stanzer, S; Janesch, B; Augustin,T; Samonigg, H; Bauernhofer, T;
Significant Improvements of psychological parameters by an educational intervention program for patients with early breast cancer.
J Clin Oncol 2008; 26(7s):A9591--44th Annual Meeting of the American Society of Clinical Oncology; May 30-June 3,; Chicago, IL, USA.
[Poster]
Andritsch, E; Ladinek, V; Zloklikovits, S; Janesch, B; Augustin, T; Samonigg, H; Bauernhofer, T;
Significant improvements of psychosocial parameters by an educational intervention program for patients with early breast cancer
ZMF Day; NOV 12 ; Graz. 2008.
[Oral Communication]
Gerger, A; Langsenlehner, U; Hofmann, G; Samonigg, H; Krippl, P
A multigenic approach to predict breast cancer risk
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A45-A45.-45.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin; Sep 17-20, 2008; Graz, AUSTRIA..
[Poster]
Web of Science
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Samonigg, H; Regitnig, P; Bauernhofer, T
Soluble E-Cadherin and ist prognostic impact on response to neoadjuvant anthracycline-based chemotherapy in breast cancer patients.
Onkologie2008; 31 (suppl 4): 161-162.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Vienna, AUSTRIA.
[Oral Communication]
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
Hereditary gene polymorphisms of vascular endothelial growth factor and colorectal cancer.
ANN ONCOL. 2008; 19(S6):68-68.-10th World Congress on Gastrointestinal Cancer; JUNE 25-28, 2008; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
Single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk
MEMO2008; Volume 1, Suppl 1: 5-5.-Frühjahrstagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie; Apr 10-12, 2008; Innsbruck, AUSTRIA.
[Poster]
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Clar, H; Krippl, P; Renner, W
Association of a common-670 A > G polymorphism in the gene of TNFRSF6 (FAS) with overall survival in colorectal cancer patients
ANN ONCOL. 2008; 19(S 6):68-68.
[Oral Communication]
Web of Science
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Samonigg, H; Szkandera, J; Krippl, P; Renner, W
Colorectal cancer survival and its association to a hereditary polymorphism in the promoter-gene of FAS
MEMO2008; Volume 1, Suppl 1: 4-5.-Frühjahrstagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 10-12, 2008; Innsbruck, AUSTRIA.
[Oral Communication]
Hofmann, G; Langsenlehner, T; Fuerst, F; Gerger, A; Langsenlehner, U; Szkandera, J; Samonigg, H; Clar, H; Krippl, P; Renner, W
Association of a common -1377 G>A polymorphism in the gene of FAS (TNFRSF6) with metastasis-free survival in rectal cancer.
Onkologie 2008; 31 (suppl 4): 104-104.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Vienna, AUSTRIA.
[Poster]
Spat, S; Habacher, W; Rakovac, I; Baumgartner, J; Schippinger, W; Samonigg, H; Pieber, TR
SHIFT OF PUBLIC HEALTH CARE EXPENDITURES FOR PALLIATIVE CANCER PATIENTS FROM INPATIENT TO OUTPATIENT EFFECTED BY HOME CARE SUPPORT TEAMS PROVIDED BY A UNIVERSITY HOSPITAL IN AUSTRIA
VALUE HEALTH. 2008; 11(6):A479-A480.
Doi: 10.1016/S1098-3015(10)66600-4
[Oral Communication]
Web of Science
FullText
FullText_MUG
Stanzer, S; Dandachi, N; Balic, M; Bauernhofer, T; Samonigg, H
The role of NKG2D expression and soluble MICA and MICB in the higher onset of apoptosis of NK cell subsets in patients with epithelial cancer
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A46-A46.
[Poster]
Web of Science
Zloklikovits, S; Ladinek, V; Andritsch, E; Samonigg, H;
How does the distress of nurses and physicians in palliative care influence their perception of patients symptoms?
Palliative Medicine, June 2008; 22 (Vol.1 suppl)(1):549-549.-5th Research Forum of the European Association for Palliative Care (EAPC); MAI 28-31, 2008; Trondheim, Norway.
[Poster]
Andritsch, E; Zloklikovits, S; Ladinek, V; Samonigg, H
Integrated Psycho-Oncology focussing the needs in palliative care: experiences and empirical data.
Oral Abstracts of the 10th Congress of the European Association for Palliative Care2007; -10th Congress of the European Association for Palliative Care; June 7-9, 2007; Budapest, HUNGARY.
[Oral Communication]
Bauernhofer,T; Schippinger,W; Weitzer,W; Stöger, H; Samonigg,H;
Neoadjuvant therapy with liposomal doxorubicin in combination with docetaxel and trastuzumab in patients with locally advanced her2/neu positive breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):9-9.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Koller, S; Weger, W; Richtig, E; Horn, M; Samonigg, H; Smolle, J
In vivo confocal laser-scanning microscopy: bringing melanoma histopathology to the bedside.
J Invest Dermatol; 2007; 127(S2):S49-S49.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland.
[Poster]
Web of Science
Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P
A multigenic approach to predict breast cancer risk.
Supplement 121; 157(25):14-14.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria.
[Poster]
Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kaessmann, H; Piswanger-Soelkner, C; Seifert, M; Schippinger, W; Menzel, C; Dubsky, P; Fitzal, F; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Jakesz, R
Bone mineral density (BMD) at 5 years after diagnosis in premenopausal patients with endocrine-responsive breast cancer, after 3 years of adjuvant endocrine treatment with goserelin and tamoxifen or anastrozole or both treatments in combination with zoledronic acid - new results from ABCSG-12
BREAST CANCER RES TREAT. 2007; 106: S8-S8.
[Oral Communication]
Web of Science
Hofmann, G; Gerger, A; Weitzer, W; Eder, T; Fürst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U
Association of common integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.
Supplement 121; 157(25):18-18.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14; 2007; Vienna, Austria.
[Poster]
Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fuerst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U
The ITGA2 807C > T polymorphism is associated with reduced colorectal cancer susceptibility
ANN ONCOL. 2007; 18: VII38-VII38.-2007 World Congress on Gastrointestinal Cancer; JUN 27-30, 2007; Barcelona, SPAIN.
[Poster]
Web of Science
Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fürst, F; Renner, W; Halm, M; Samonigg, H; Krippl, P; Langsenlehner, U
Common integrin receptor gene polymorphisms and their impact on colorectal cancer susceptibility
Onkologie2007; 30(S 3):12-12.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel, SWITZERLAND. (ISBN: 978-3-8055-8431-9 )
[Oral Communication]
Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Yazdani-Biuki, B; Renner, W; Fürst, F; Samonigg, H; Krippl, P; Langsenlehner, U
Classification tree analysis of functional genetic polymorphisms predicts breast cancer risk
Onkologie2007; 30(S 3):52-52.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel, SWITZERLAND. (ISBN: 978-3-8055-8431-9 )
[Oral Communication]
Hofmann, G; Krippl, P; Eder, T; Fürst, F; Gerger, A; Renner, W; Weitzer, W; Samonigg, H; Langsenlehner, U
The hereditary 936 C/T polymorphism in the vascular endothelial growth factor gene is not associated with colorectal cancer susceptibility.
Supplement 121; 157(25):17-17.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria.
[Poster]
Horn, M; Gerger, A; Ahlgrimm-Siess, V; Weger, W; Koller, S; Kerl, H; Samonigg, H; Smolle, J; Hofmann-Wellenhof, R
Diagnostic in vivo confocal laser-scanning microscopy of actinic keratoses
J INVEST DERMATOL. ; 127: S41-S41.-68th Annual Meeting of the Society for Investigative Dermatology; May 9-12, 2007; Los Angeles, USA.
[Poster]
Web of Science
Horn, M; Gerger, A; Wiltgen, M; Langsenlehner, U; Hofmann-Wellenhof, R; Weger, W; Richtig, E; Samonigg, H; Smolle, J
Diagnostic image analysis of malignant melanoma in in-vivo confocal laser-scanning microscopy.
J Invest Dermatol;2007; 127(S2):S91-S91.-37 th Annual ESDR Meeting; SEP 5-8, 2007; Zürich, Switzerland.
[Poster]
Web of Science
Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
TRAIL receptors as prognostic factors in non-small cell lung cancer
Scientific Lung Day Graz; APR 28, 2007; Graz, AUSTRIA. 2007.
[Poster]
Leithner, K; Stacher, E; Wurm, R; Ploner, F;Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
TRAIL receptors as prognostic factors in non-small cell lung cancer
European Respiratory Journal 2007; 30(S 51):716s-716s.-17th European Respiratory Socienty Annual Congress; SEPT 15-19, 2007; Stockholm, SWEDEN.
[Oral Communication]
Lileg, B; Weitzer, W; Stöger, H; Samonigg, H
A phase II clinical trial of Bicalutamide in patients with metastatic breast cancer expressing Androgen receptor.
2007; -ÖGHO-Jahrestagung; Apr 12-14, 2007; Vienna, Austria.
[Poster]
Öfner, D; de Vries, A; Thaler, J; Eisterer, R; Greil, R; Lukas, P; Rabl, H; Samonigg, H; Kapp, K; Gnandt, M
Preoperative Oxaliplatin (o), capecitabine (X), and external beam radiotherapy (RT) in patients with newly diagnosed, primary operable, locally advanced rectal cancer (LARC).
Proceedings of the Annual Meeting of the American Society of Clinical Oncology (ASCO)2007; -Annual Meeting of the American Society of Clinical Oncology (ASCO).; JUN 1-5, 2007; Chicago, USA.
[Oral Communication]
Pichler, M; Hoefler, G; Maderbacher, M; Gülly, C; Bauernhofer, T; Samonigg, H; Dandachi, N
Comparison of High Resolution Melting Analysis, Denaturing High Pressure Liquid Chromatography and DNA Sequencing for detection of Mutations in human colorectal tumor samples
2nd Gene Expression Symposiom; Oct 2007; Graz, Austria. 2007.
[Poster]
Pichler, M; Tockner, S; Bauernhofer, T; Samonigg, H; Dandachi, N
Comparison of real-time PCR instruments for the detection of melanoma cell markers
Clinical Chemistry and Laboratory Medicine2007; -Gemeinsamer Kongress der
Österreichischen Gesellschaft
für Laboratoriumsmedizin und Klinische Chemie (ÖGLMKC) und der
Deutschen Vereinten Gesellschaft
für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 19-22, 2007; Vienna, Austria.
[Poster]
Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Schug, A; Bauernhofer, T; Samonigg, H
Influence of neoadjuvant chemotherapy on the HER-2/neu status of breast cancer tissue.
Supplement 121; 157(25):28-28.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, AUSTRIA .
[Poster]
Schippinger, W; Lileg, B; Ploner, F; Weitzer, W; Bauemhofer, T; Samonigg, H
Neoadjuvant chemotherapy with non-pegylated liposomal doxorubicin, docetaxel and trastuzumab in HER-2/neu overexpressing breast cancer
ANN ONCOL. 2007; 18: 166-166.
[Poster]
Web of Science
Schippinger,W; Regitnig,P; Dandachi,N; Wernecke,KD; Bauernhofer,T; Samonigg,H;Moinfar, F;
Examination of the prognostic significance of androgen receptor expression in metastatic breast cancer
Wiener Medizinische Wochenschrift2007; 157(121):8-8.-Frühjahrestagung 2007
der Österreichischen Gesellschaft für Hämatolgie und Onkologie (ÖGHO)
und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich (AHOP)
; APR 12-14, 2007; Vienna, Austria.
[Oral Communication]
Stanzer, S; Dandachi, N; Balic, M; Janesch, B; Resel, M; Samonigg, H; Bauernhofer, T
Higher turnover of NK cells and NK cell subpopulations in patients with metastatic epithelial cancer
World Immune Regulation Meeting; APR 11-15, 2007 ; Davos, Switzerland. 2007.
[Poster]
Weger, W; Gerger, A; Samonigg, H; Kränke, B; Salmhofer, W; Aberer, E
Capecitabine-induced subacute cutaneous lupus erythematosus.
Wiener Medizinische Wochenschrift; 157(S121):34-34.-Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; April 12-14, 2007; Vienna, Austria.
[Poster]
Zatloukal K, Gottweis H, Eder J, Trauner M, Denk H, Samonigg H, Stöger U
GATiB, Genome Austria Tissue Bank
GEN-AU Evaluierungskonferenz; APRIL, 16-17, 2007; Vienna, AUSTRIA. 2007.
[Oral Communication]
Zloklikovits, S; Ladinek, V; Andritsch, E; Samonigg, H
Comparisons of patient and caregiver symptom ratings in palliative care: the role of their subjective distress.
PSYCHO-ONCOL. 2007; 16(9):S30-S31.-IPOS 9th World Congress of Psycho-Oncology; SEP 16-21, 2007; London, United Kingdom.
[Oral Communication]
Web of Science
Andritsch, E; Dietmaier, G; Bauernhofer, T; Samonigg, H
The influence of an artistic ward design on the wellbeing of cancer patients at the Division of Oncology at the Medical University of Graz
PSYCHO-ONCOL. 2006; 15(2):S71-S71.-8th World Congress of Psycho-Oncology; OCT 16-21, 2006; Ferrara-Venice, Italy.
[Poster]
Web of Science
Andritsch, E; Dietmaier, G; Hofmann, G; Ladinek, V; Zloklikovits, S; Petru, E; Samonigg, H
Coping and Survival in Breast Cancer Patients evaluated in a 5-Year Follow-up.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S 2006; -2006 ASCO Annual Meeting ; June 2-6, 2006; Georgia, Atlanta.
[Poster]
Andritsch, E; Dietmaier, G; Zloklikovits, S; Ladinek, V; Samonigg, H
Psychologischer Distress und Coping bei Brustkrebspatientinnen: Einfluss von Alter, Partnerbeziehung und Aktivität (Beruf, Freizeitverhalten).
-7. Tagung der Österreichischen Gesellschaft für Psychologie; APR 28-30, 2006; Klagenfurt, AUSTRIA.
[Oral Communication]
Andritsch, E; Ladinek, V; Zloklikovits, S; Stanzer, S; Bauernhofer, T
Identifying symptom burden and distress of cancer patients with chemotherapy: A pilot study for an Austrian sample
PSYCHO-ONCOL. ; 15(2):S158-S159.
[Poster]
Web of Science
Bauernhofer, T; Andritsch, A; Ladinek, V; Zloklikovits, S; Stanzer, S; Janesch, B; Halm, M; Dandachi, N; Samonigg, H
Influence of Psychosocial Intervention on T and NK Cell Subsets in Patients with Breast Cancer
ZMF Tag; OCT 24, 2006; Graz, AUSTRIA. 2006.
[Poster]
Bauernhofer, T; Samonigg, H; Regitnik, P; Lileg, B; Weizer, W; Waxenecker, G; Kainer, M; Wiederkum, S; Loibner, H; Kircheis, R
A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion.
J CLIN ONCOL. 24(18):111S-111S.-Asco-Meetung; 2.-6. Juni 2006; Atlanta/ Georgia, USA.
[Poster]
Web of Science
Dietmaier, G; Ladinek, V; Samonigg, H; Andritsch, E
The relation between coping, meaning in life, recurrence and survival and in a sample of Austrian breast cancer patients
PSYCHO-ONCOL. 2006; 15(2):S132-S133.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, ITALY.
[Oral Communication]
Web of Science
Fotter, R; Samonigg, H
Brustkrebs: Früherkennung und neueste Behandlungsmethoden.
Mini Med Studium Steiermark; Nov 15, 2006; Graz, AUSTRAIA. 2006.
[Keynote lecture]
Gerger, A; Horn, M; Samonigg, H; Langsenlehner, U; Krippl, P; Kerl, H; Smolle, J
Diagnostic virtual histopathology of untreated fresh specimens from squamous cell carcinoma using confocal laser-scanning microscopy
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France.
[Oral Communication]
Web of Science
Gerger, A; Kerl, H; Samonigg, H; Langsenlehner, U; Krippl, P; Smolle, J
Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
J INVEST DERMATOL. 126: 114-114.-European Society of Dermatological Research; Sep, 2006; Paris, France.
[Poster]
Web of Science
Gerger, A; Koller, S; Weger, W; Richtig, E; Kerl, H; Samonigg, H; Smolle, J
Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8, 2006; Graz, AUSTRIA. 2006.
[Keynote lecture]
Gerger, A; Samonigg, H; Krippl, P; Smolle, J
Sensitivity and specificity of confocal laser scanning microscopy for in vivo diagnosis of malignant skin tumors
-Österreichische Gesellschaft für Hämato-Onkologie; April, 2006; Wels.
[Poster]
Gerger, A; Smolle-Jüttner, F; Samonigg, H; Hegenbarth, K; Smolle, J
Asymptomatic primary malignant melanoma of the esophagus
Österreichische Gesellschaft für Hämato-Onkologie; APR 2006; Wels. 2006.
[Oral Communication]
Gnant, M; Greil, R; Kubista, E; Menzel, C; Schippinger, W; Seifert, M; Haider, K; Mlineritsch, B; Samonigg, H; Kwasny, W; Fridrik, M; Steger, G; Steindorfer, P; Schmelitsch, J; Poetter, R; Jakesz, R
The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year results of ABCSG-05 (CMF vs. goserelin plus tamoxifen).
BREAST CANCER RES TREAT. 2006; 100: S10-S11.
[Poster]
Web of Science
Grebe, Ch; Reiner, F; Lientscher, M; Samonigg, H; Strohscheer, I
Vergleich der Patientencharakteristika von zwei Palliativstationen
-2. Österreichischer Interdisziplinärer Palliativkongress; Dez, 07-09,2006; Salzburg.
[Poster]
Hofmann, G; Langsenlehner, U; Eder, T; Renner, W; Fürst, F; Samonigg, H; Krippl, P
Association of a functional single nucleotide polymorphism in the Vascular Endothelial Growth Factor gene with colorectal cancer susceptibility.
Onkologie. 29(S3):138-138.-Gemeinsame Jahrestagung der
Deutschen, Österreichischen und Schweizerischen
Gesellschaften für Hämatologie und Onkologie; NOV 4-8, 2006; Leipzig, GERMANY. (ISBN: 3-8055-8214-5 )
[Poster]
Hofmann, G; Langsenlehner, U; Renner, W; Greimel, A; Eder, T; Samonigg, H; Krippl, P
Zusammenhang von Metastasierungsrisiko bei Brustkrebspatientinnen und einem Polymorphismus im CD-95 (FAS) Gen.
-52. Ausseer Symposium der Wissenschaftlichen Gesellschaft der Ärzte in der Steiermark; MAY 11-13, 2006; Bad Aussee, Austria.
[Oral Communication]
Hofmann ,G; Langsenlehner, U; Renner, W; Greimel, A; Eder, T; Samonigg, H; Krippl, P
Association of a common -1377G > A polymorphism in the gene of TNFRSF6 (FAS) with decreased risk for breast cancer metastasis.
Wiener Medizinische Wochenschrift. 156/25(S118):10-10.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie.; APRIL 27-29, 2006; Wels, AUSTRIA.
[Poster]
Hofmann, G; Langsenlehner, U; Weitzer, W; Eder, T; Samonigg, H; Krippl, P
First description of response to gemcitabine treatment in a patient with advanced pri-mary adenocarcinoma of the epididymis.
Wiener Medizinische Wochenschrift. 156/25(S118):9-9.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 27-29, 2006; Wels, AUSTRIA.
[Poster]
Ladinek, V; Zloklikovits, S; Adritsch, E; Samonigg, H
The observed versus estimated quality of perception of patient symptoms reported by healthcare professionals in palliative care
PSYCHO-ONCOL. 2006; 15(2):S298-S298.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, ITALY.
[Poster]
Web of Science
Langsenlehner, U; Eder, T; Renner, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P
The cyclooxygenase-2 (PTGS2) 8473T > C polymorphism increases breast cancer risk.
BREAST CANCER RES TREAT. 2006; 100: S251-S252.-29th Annual San Antonio Breast Cancer Symposium; DEC 14-17, 2006; San Antonio, USA.
[Poster]
Web of Science
Langsenlehner, U; Eder,T; Weitzer, W; Gerger, A; Hofmann, G; Samonigg, H; Krippl, P
The homozygous cyclooxygenase-2 (PTGS2) 8473CC genotype is associated with breast cancer risk and estrogen receptor positivity.
Onkologie. 29(S3):127-127.-Gemeinsame Jahrestagung der
Deutschen, Österreichischen und Schweizerischen
Gesellschaften für Hämatologie und Onkologie; NOV 4-8, 2006; Leipzig, GERMANY. (ISBN: 3-8055-8214-5 )
[Poster]
Langsenlehner, U; Hofmann, G; Eder, T; Weitzer, W; Gerger, A; Samonigg, H; Krippl, P
The cyclooxygenase-2 (PTG52) 8473T>C polymorphism increases breast cancer susceptibility.
236-236.-19th Meeting of the European Association for Cancer Research (EACR); JULY 1-4, 2006; Budapest, HUNGARY.
[Poster]
Langsenlehner, U; Hofmann, G; Eder, T; Weitzer, W; Samonigg, H; Krippl, P
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism increases breast cancer susceptibility
Wiener Medizinische Wochenschrift. 156/25(S118):13-13.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 27-29, 2006; Wels, AUSTRIA.
[Poster]
Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
Expression of death receptor 5 (DR5) as prognostic factor in advanced non-small cell lung cancer (NSCLC)
Jahrestagung der österreichischen Gesellschaft für Lungenheilkunde; NOV 6-9, 2006; Graz, Austria. 2006.
[Oral Communication]
Leithner, K; Stacher, E; Wurm, R; Ploner, F; Quehenberger, F; Polachova, J; Samonigg, H; Popper, H; Olschewski, H
Cytoplasmic staining for survivin is associated with poor chemotherapy response in non-small cell lung cancer (NSCLC).
ÖGP Jahrestagung ; NOV 6-9, 2006; Graz, Austria. 2006.
[Poster]
Leithner, K; Stacher, E; Wurm, R; Popper, H; Samonigg, H; Ploner, F; Polachova, J; Olschewski, H
Death receptor 5 and survivin as prognostic markers in advanced NSCLC.
-23rd Annual Meeting of the Austrian Society of Surgical Oncology
(ACO-ASSO) - 11th International Thoracic Surgery Congress; OCT 5-7, 2006; St. Wolfgang, Austria.
[Poster]
Lientscher, M; Strohscheer, I; Samonigg, H
Kann eine passagere NMDA-Rezeptor-Blockade Effekte auf die Opaitverträglichkeit haben?
-6. Kongress der Deutschen Gesellschaft für Palliativmedizin; Sep 21-23, 2006; Hamburg.
[Poster]
Lileg, B; Schmid, M; Watzinger, N; Samonigg, H
Myocardial infection after chemotherapy for testicular cancer: A cumulative case report.
Wiener Medizinische Wochenschrift. 118: 14-14.-ÖGHO; May, 2006; Wels, Austria.
[Poster]
Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R
A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA.
[Poster]
Web of Science
Reuler, AAHVv; Kerkhoff, AHM; Samonigg, H; Strohscheer, I
Organisation of palliative care in Austria and The Netherlands - can learn from each other?
-4th Research Forum of the EAPC 2006
; MAI, 24-27, 2006; Venedig, Italien.
[Poster]
Riederer, M; Richtig, E; Dandachi, N; Resel, M; Tockner, S; Gerger, A; Kerl, H; Samonigg, H; Bauernhofer, T
Quantitative detection of circulating tumor cells in peripheral blood of melanoma patients using multimarker real-time PCR and immunomagnetic cell sorting: A preclinical evaluation
ZMF Day ; 24.11.06; Graz, Austria. 2006.
[Poster]
Samonigg, H
Space light, colours. Architectural environment and quality of life in cancer patients
PSYCHO-ONCOL. ; 15(2):S72-S72.
[Poster]
Web of Science
Samonigg, H
The model of cooperation between the Austrian Society of Haematology and Oncology and the Austrian Association of Psycho-oncology
PSYCHO-ONCOL. ; 15(2):S31-S31.
[Oral Communication]
Web of Science
Samonigg, H; Andritsch, E; Dietmaier, G; Bauernhofer, T; Andritsch, H; Zloklikovits, S; Kasparek, AK; Stoeger, H; Schaberl-Moser, R; Ploner, F
Healing by Design: the Influence of an Artistic Design on the Wellbeing of Cancer Patients-- a 10 Years Follow Up.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. (June 20 Supplement); 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Stanzer, S; Dandachi, N; Balic, M; Resel, M; Janesch, B; Samonigg, H; Bauernhofer, T
Increase in the Number and Resistance to Programmed Cell Death of CD4+CD25+high regulatory T cells in Patients with Metastatic Epithelial Cancer.
ZMF Tag; OCT 24, 2006; Graz, AUSTRIA. 2006.
[Poster]
Steger, GG; Greil, R; Samonigg, H; Jakesz, R; Bartsch, R; Mlineritsch, B; Melbinger-Zeinitzer, E; Marth, C; Schippinger, W; Gnant, MF
An interim safety analysis of ABCSG-24: 6 cycles of docetaxel, epirubicin, and capecitabine plus pegfilgrastim (DEC) vs. 6 cycles of docetaxel and epirubicin plus pegfilgrastim (DE) in the neoadjuvant treatment of operable breast cancer.
BREAST CANCER RES TREAT. 2006; 100: S156-S156.
[Poster]
Web of Science
Strohscheer, I; Bachmann, F; Maschmayer, G; Samonigg, H
Frequency, causes and outcome of the use of antibiotics in terminal cancer patients
-4th Research Forum of the EAPC 2006
; Mai 24-27, 2006; Venedig, Italien.
[Poster]
Strohscheer, I; Bachmann, F; Maschmeyer, G; Samonigg, H
Retrospektive Auswertung des Einsatzes von Antibiotika auf einer Palliativstation
-6. Kongress der Deutschen Gesellschaft für Palliativmedizin; Sep 21-23,2006; Hamburg.
[Poster]
Strohscheer, I; Bachmann, F; Maschmeyer, G; Samonigg, H
Characteristics and frequency of treatment with antibiotics on a Palliative Care Unit
-31st ESMO Congress.; Sep 29-Okt 03, 2006; Istanbul, Türkei.
[Poster]
Strohscheer, I; Schippinger, W; Samonigg, H
Behandlung einer therapierefraktären Hyperkalzämie bei fortgeschrittenenm Mammakarzinom durch Chemotherapie
-6. Kongress der Deutschen Gesellschaft für Palliativmedizin
; SEP 21-23, 2006; Hamburg.
[Poster]
Verebes, J; Borasio, GD; Samonigg, H; Strohscheer, I
Entwicklung einer standardisierten Dokumentation für palliativmedizinische Konsiliardienste in Krankenhäusern
-6. Kongress der Deutschen Gesellschaft für Palliativmedizin
; SEP 21-23, 2006; Hamburg.
[Poster]
Weitzer, W; Bauernhofer, T; Stoeger, H; Langsenlehner, U; Lax, S; Samonigg, H
High-grade endometrial stroma sarcoma treated with aromatase inhibitor letrozole
Wiener Medizinische Wochenschrift. 156(25):9-9.-Frühjahrstagung 2006 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 27-29, 2006; Wels, AUSTRIA.
[Poster]
Weitzer, W; Hofmann, G; Eder, T; Samonigg, H; Krippl, P; Langsenlehner, U
Integrin alpha-2 and beta-3 gene polymorphisms are associated with reduced breast cancer risk.
Wiener Medizinische Wochenschrift. 156/25(S118):4-5.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APRIL 27-29, 2006; Wels, AUSTRIA.
[Oral Communication]
Zloklikovits, S; Andritsch, E; Ladinek, V; Samonigg, H
Selbst- versus Fremdeinschätzung der Symptomintensitäten von Palliativpatienten
-7. Tagung der Österreichischen Gesellschaft für Psychologie; APR 28-30, 2006; Klagenfurt, AUSTRIA.
[Oral Communication]
Zloklikovits, S; Ladinek, V; Andritsch, E; Greimel, A; Pilgram, EH; Strohscheer, I; Verebes, J; Springer-Schlegl, I; Stöger, H; Samonigg, H
Influence of the level of subjective distress of healthcare professionals on the perception of symptom intensity reported by patients with terminal cancer.
Journal of Clinical Oncology. 2006 ASCO Annual Meeting Proceedings Part I. ; 24(18S):-2006 ASCO Annual Meeting; JUNE 2-6, 2006; Atlanta, USA.
[Poster]
Zloklikovits, S; Ladinek, V; Andritsch, E; Samonigg, H
Symptom assessment in palliative care: A comparison of terminal cancer patients and their family caregivers
PSYCHO-ONCOL. 2006; 15(2):S415-S416.-8th world congress of psycho-oncology; OCT 16-21, 2006; Ferrara-Venice, ITALY.
[Poster]
Web of Science
Himmler, G; Settaf, A; Groiss, F; Eller, N; Salzberg, M; Kundi, M; Eckert, H; Loibner, H; Samonigg, H
A randomized placebo-controlled phase II study with the cancer vaccine candidate IGN101 in patients with epithelial cancers.
J CLIN ONCOL 2005 23: 179S-179S.
Web of Science
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Resel, M; Wernecke, KD; Samonigg, H; Bauernhofer,T;
Serum levels of soluble E-cadherin as possible predictive and prognostic marker in female breast cancer patients undergoing neoadjuvant therapy.
Wiener Medizinische Wochenschrift2005; 155(117):2-3.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO)und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich
; APR 28-30, 2005; Graz, Austria.
[Oral Communication]
Hofmann, G; Dandachi, N; Balic, M; Schippinger, W; Wernecke, KD; Samonigg, H; Bauernhofer, T
Quantitative measurement of soluble E-cadherin in sera of breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy and its predictive and prognostic value.
J CLIN ONCOL 2005 23: 70S-70S.
Web of Science
Hofmann, G; Langsenlehner, U; Renner, W; Greimel, A; Samonigg, H; Krippl, P
Breast cancer metastasis-free survival and its association to a common hereditary gene polymorphism of cyclin D1
BREAST CANCER RES TREAT. 94: S-78-S-79.
Web of Science
Hofmann, G; Langsenlehner, U; Renner, W; Greimel, A; Samonigg, H; Krippl, P
A single nucleotide polymorphism in the CCND1 gene is associated with decreased risk of developing metastases in female breast cancer patients
EJC SUPPL. 2005; 3(2): 46-47.
Web of Science
Jakesz, R; Gnant, M; Greil, R; Tausch, C; Samonigg, H; Kwasny, W; Kubista, E; Stierer, M; Luschin, G; Mittlboeck, M
The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormone-responsive early breast cancer: 5 year-analysis of ABCSG Trial 8
BREAST CANCER RES TREAT. 2005; 94: S10-S10.
Web of Science
Jakesz, R; Samonigg, H; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mlineritsch, B; Tausch, C; Stierer, M
Extended adjuvant treatment with anastrozole: Results from the Austrian breast and colorectal cancer study group trial 6a (ABCSG-6a).
J CLIN ONCOL 2005 23: 10S-10S.
Web of Science
Langsenlehner, U; Eder, T; Weitzer, W; Samonigg, H; Krippl, P
The most common integrin ITGA2 haplotype (807C_1648G, wildtype) is associated with decreased breast cancer risk
BREAST CANCER RES TREAT 2005 94: -.
Web of Science
Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg, H
Interleukin-10 TCATA haplotype is associated with decreased breast cancer risk
ANN ONCOL 2005 16: 271-271.
Web of Science
Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg H
Genetic variants of the Interleukin-10 promoter and its association with decreased breast cancer risk
Wiener Medizinische Wochenschrift Suppl. 2005; (117):8-8.-ÖGHO Frühjahrstagung; APRIL 28-30, 2005; Graz, AUSTRIA.
[Poster]
Langsenlehner, U; Weitzer, W; Hofmann, G; Eder, T; Samonigg, H; Krippl, R
Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk
EJC SUPPL. 2005; 3(2): 84-84.
Web of Science
Lileg, B; Bauernhofer,T; Popper, H; Ranner,G; Samonigg, H;
C-kit expression of an extra-abdominal desmoid tumor and response to imatinib mesylate therapy
Wiener Medizinische Wochenschrift2005; 155(117):16-17.-
Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich ; APR 28-30, 2005; Graz, Austria.
[Poster]
Samonigg, H; Himmler, G; Gnant, M; Gastl, G; Loibner, H; Possinger, K; Bauernhofer, T; Dandachi, N; Balic, M; Steger, G; Obwaller, A
A multicenter phase II, open-label trial of multiple doses of cancer vaccine candidate IGN101 to evaluate efficacy against disseminated tumor cells in blood.
J CLIN ONCOL 2005 23: 180S-180S.
Web of Science
Schippinger,W; Regitnig,P; Moinfar,F; Dandachi,N; Bauernhofer,T; Wernecke,WD; Samonigg,H;
Häufigkeit der Expression von Androgen-Rezeptoren beim Mammakarzinom.
Wiener Medizinische Wochenschrift2005; 155(117):11-11.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Stanzer, S; Dandachi, N; Resel, M; Balic, M; Samonigg, H; Bauernhofer, T;
High TurnOver of CD4+CD25+ T cell Subpupulation in patients with Metastatic epithelial cancer
Wiener Medizinische Wochenschrift2005; 155(117):19-20.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Wagner P, Schaberl-Moser R, Langsenlehner U, Stranzl H, Gabor S, Samonigg H
Postoperative chemoradiation therapy in patients with esophageal cancer- A pilot study
Wiener Med Wochenschrift2005; 117: 14--ÖGHO; 28.-29. April 2005; Graz.
[Poster]
Weitzer, W; Regauer,S; Schöllnast, H; Eder,T; Vrecl, R; Bauernhofer,T; Samonigg, H;
Partial remission of a metastasized epitheloid sarcoma with anti-estrogen therapy with tamoxifen A case report
Wiener Medizinische Wochenschrift2005; 155(117):20-21.-Frühjahrstagung 2005 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO) und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 28-30, 2005; Graz, Austria.
[Poster]
Andritsch, E; Baider, L; Dietmaier, G; Samonigg, H
Identifying predictors of quality of life in a randomized sample of breast cancer patients
PSYCHO-ONCOL 2004 13: S154-S155.
Web of Science
Dietmaier, G; Samonigg, H; Andritsch, E
Coping with breast cancer - What did help patients and partners most? A pilot study
PSYCHO-ONCOL. 13: S52-S52.-7th World Congress of Psycho-Oncology; AUG 25-28, 2004; Copenhagen, DENMARK.
Web of Science
Eder, T; Andritsch, E; Balic, M; Stöger, H; Samonigg H
Durchgangssyndrom bei fortgeschrittener Tumorerkrankung.
Differenzialdiagnostische Überlegungen anhand eines Fallberichts.
Kongressband des 50. Ausseer Symposium 2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Oral Communication]
Eder, T; Weitzer, W; Schmid, M; Samonigg, H
Solitäre Knochenmetastase eines Rectumkarzinoms. Ein Fallbericht.
Kongressband des 50. Ausseer Symposium2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Poster]
Gnant, M; Jakesz, R; Mlineritsch, B; Luschin-Ebengreuth, G; Schmid, M; Menzel, C; Kubista, E; Samonigg, H; Hausmaninger, H
Zoledronic acid effectively counteracts cancer treatment induced bone loss (CTIBL) in premenopausal breast cancer patients receiving adjuvant endocrine treatment with goserelin plus anastrozole versus goserelin plus tamoxifen - bone density subprotocol results of a randomized multicenter trial (ABCSG-12)
BREAST CANCER RES TREAT. 2004; 88: S8-S9.
Web of Science
Jakesz, R; Kaufmann, M; Gnant, M; Jonat, W; Mittlboeck, M; Greil, R; Tausch, C; Hilfrich, J; Kwasny, W; Samonigg, H
Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3,123 women enrolled in the ABCSG trial 8 and the ARNO 95 trial
BREAST CANCER RES TREAT. 2004; 88: S7-S7.
Web of Science
Krippl, P; Langsenlehner, U; Eder, T; Samonigg, H
The 5A/6A polymorphism of the stromelysin I gene promotor and breast cancer
BRIT J CANCER 2004 91: S25-S25.
Web of Science
Krippl, P; Langsenlehner, U; Samonigg, H
The 825C > T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer
BRIT J CANCER 2004 91: S56-S56.
Web of Science
Krippl, P; Langsenlehner, U; Worm, HC; Samonigg, H
Einfluss eines Polymorphismus im Gen des GNB-3 und Metastasenrisiko bei Brustkrebspatienten
50. Ausseer Symposion, Wiss. Ges. der Ärzte in der Steiermark, , Bad Aussee. P 09; Mai 6-92004; Bad Aussee. 2004.
[Poster]
Krippl, P; Langsenlehner, U; Worm, HC; Samonigg, H
Gen-Polymorphismen der Matrixmetalloproteinasen 1, 3 und 9 und Brustkrebs
50. Ausseer Symposion, Wiss. Ges. der Ärzte in der Steiermark, 6.-9.05.2004, Bad Aussee. P 082004; -50. Ausseer Symposion, Wiss. Ges. der Ärzte in der Steiermark, ; MAI 6-9 2004; Bad Aussee.
[Poster]
Langsenlehner, U; Eder, T; Wagner, P; Ploner, F; Samonigg, H
Niedrig differenziertes neuroendokrines Karzinom und Flushsymptomatik- eine ungewöhnliche Konstellation mit therapeutischer Option
Kongressband des 50. Ausseer Symposium 2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Poster]
Langsenlehner, U; Eder, T; Weitzer, W; Krippl, P; Samonigg, H
Entwicklungen in der endokrinen Therapie des Mammakarzinoms. Daraus resultierende Vorteile anhand eines Fallberichts.
Kongressband des 50. Ausseer Symposium2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Poster]
Langsenlehner, U; Krippl, P; Eder, T; Samonigg, H
The SULT1A1 213H variant is associated with the presence of lymph node metastases in breast cancer patients
BRIT J CANCER 2004 91: S26-S26.
Web of Science
Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg, H
Der 638 G/A Polymorphismus vom Sulfotransferase 1A1 Gen und sein Einfluss auf das Brustkrebsrisiko
Onkologie, Supplement 3 2004; 27: 463-463.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 2-6, 2004; Innsbruck, AUSTRIA.
[Oral Communication]
Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg, H
Higher risk for lymph node metastases of breast cancer patients with the 638 G>A polymorphism in the sulfotransferase 1A1 gene
Annals of Oncology, Abstract Book of the 29th ESMO Congress 2004; 61-61.-29th ESMO Congress, Wien; OCT 29- NOV 2, 2004; Vienna, AUSTRIA.
[Oral Communication]
Langsenlehner, U; Krippl, P; Renner, W; Eder, T; Samonigg, H
The frequency of the 638 G>A polymorphism of the sulfotransferase 1A1 gene is increased in lymph node positive breast cancer patients
Acta Medica Austriaca 2004; 31(63):12-12.-ÖGHO Jahrestagung; APRIL 15-17, 2004; Vienna, AUSTRIA.
[Poster]
Langsenlehner, U; Krippl, P; Samonigg, H
The 677C > T polymorphism of methylenetetrahydro folate reductase gene and susceptibility to breast cancer
BRIT J CANCER 2004 91: S26-S26.
Web of Science
Langsenlehner, U; Samonigg, H; Krippl, P
The-1377G > A polymorphism in the FAS promoter region is associated with increased breast cancer susceptibility.
BREAST CANCER RES TREAT 2004 88: S72-S72.
Web of Science
Langsenlehner, U; Samonigg, H; Krippl, P
Vascular endothelial growth factor gene polymorphism decreases the risk for breast cancer metastasis.
BREAST CANCER RES TREAT 2004 88: S144-S145.
Web of Science
Loibner, H; Eckert, H; Eller, N; Groiss, F; Himmler, G; Rosenkaimer, F; Salzberg, R; Samonigg, H; Schuster, M; Settaf, A
A randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial solid organ tumors (IGN101/2-01)
J CLIN ONCOL. 2004; 22(14): 192S-192S.
Web of Science
Schmid, P; Schippinger, W; Nitsch, T; Huebner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, M; Samonigg, H; Possinger, K
Up-front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial.
J CLIN ONCOL 2004 22: 37S-37S.
Web of Science
Steger, GG; Kubista, E; Hausmaninger, H; Gnant, M; Tausch, C; Lang, A; Samonigg, H; Galid, A; Jakesz, R
6 vs. 3 Cycles of epirubicin/docetaxel plus G-CSF in operable breast cancer: Results of ABCSG-14
J CLIN ONCOL 2004 22: 15S-15S.
Web of Science
Weitzer, W; Bauernhofer, T; Eder, T; Langsenlehner, U; Samonigg, H
Corticosteroidtherapie bei retroperitonealer Fibrose- ein Fallbericht
Kongressband des 50. Ausseer Symposium 2004; -50. Ausseer Symposium; MAY 6-9, 2004; Bad Aussee, AUSTRIA.
[Poster]
Balic, M; Bauernhofer, T; Hofmann, G; Dandachi, N; Himmler, G; Obwaller, A; Oberkleiner, P; Grunt, S; Loibner, H; Samonigg, H
Evaluation of epithelial cell enumeration methods to detect tumor cells of cancer patients
Proc Am Soc Clin Oncol 2003; 22:(abstr 3607): -Annual Meeting of the American Society of Clincal Oncology (ASCO); MAY 31 - JUN 3, 2003; Chicago, Ill., USA.
[Poster]
Filipits, M; Pohl, G; Rudas, M; Dietze, O; Lax, S; Pirker, R; Zielinski, CC; Kubista, E; Samonigg, H; Jakesz, R
Predictive value of p27KIP1 expression in premenopausal women with early-stage hormone receptor-positive breast cancer.
J CLIN ONCOL 2003 21: 288S-288S.
Web of Science
Krippl, P; Langsenlehner, U; Renner, W; Samonigg, H
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
BREAST CANCER RES TREAT 2003 82: S140-S140.
Web of Science
Obwaller, A; Balic, M; van der Kooi, A; Dandachi, N; Himmler, G; Mudde, GC; Peball, B; Grunt, S; Oberkleiner, P; Doyle, GV; Terstappen, LWMM; Bauernhofer, T; Samonigg, H; Loibner, H
Comparative analysis of three different methods for the detection of disseminated tumor cells
J IMMUNOTHER 2003 26: S49-S50.
Web of Science
Samonigg, H; Hofmann, G; Bauernhofer, T; Balic, M; Stöger, H; Groiss, F; Himmler, G; Schuster, M; Rosenkaimer, F; Loibner, H
Phase if trial to explore the influence of concomitant chemotherapies on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
J IMMUNOTHER 2003 26: S14-S14.
Web of Science
Samonigg, H; Hofmann, G; Bauernhofer, T; Balic,M; Stoeger, H; Himmler, G; Schuster, M; Rosenkaimer, F; Groiss,F; Loibner, H;
Phase II trial to explore the influence of concomitant chemotherapy on the immunogenicity of the cancer vaccine IGN101 in patients with epithelial cancers
Proc Am Soc Clin Oncol 2003; 22:(abstr 683): -Annual Meeting of the American Society of Clinical Oncology (ASCO); May 31-JUN 3, 2003; Chicago, Ill., USA.
[Poster]
Schippinger, W; Bauernhofer, T; Regitnig, P; Ploner, F; Krippl, P; Hofmann, G; Lax, S; Carney, W; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu dynamics in metastatic breast cancer as an independent prognostic factor.
BREAST CANCER RES TREAT 2003 82: S123-S123.
Web of Science
Schmid, P; Schippinger, W; Nitsch, T; Huenbner, G; Kreienberg, R; Schultze, W; Hausmaninger, H; Wischnewsky, MB; Luftner, D; Samonigg, H; Possinger, K
Up front tandem high-dose chemotherapy compared to standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: updated results of a randomized trial
BREAST CANCER RES TREAT 2003 82: S152-S152.
Web of Science
Gnant, M; Hausmaninger, H; Samonigg, H; Mlineritsch, B; Taucher, S; Luschin-Ebengreuth, G; Jakesz, R
Changes in bone mineral density caused by anastrozole or tamoxifen in combination with goserelin (+/- zoledronate) as adjuvant treatment for hormone receptor-positive premenopausal breast cancer: results of a randomized multicenter trial.
BREAST CANCER RES TREAT. 2002; 76: S31-S31.
Web of Science
Jakesz, R; Hausmaninger, H; Kubista, E; Gnant, M; Seifert, M; Kwasny, W; Steger, G; Samonigg, H; Tausch, C; Stierer, M
The prognostic value of HER-2/neu status in premenopausal patients with hormone-responsive breast cancer.
BREAST CANCER RES TREAT. 2002; 76: S44-S44.
Web of Science
Jakesz, R; Samonigg, H; Hausmaninger, H
Progesterone receptor quality and level have a significant prognostic and predictive impact in pre- and postmenopausal patients with hormone-responsive breast cancer: six-year results of ABCSG trials 5 and 6.
BREAST CANCER RES TREAT. 2002; 76: S45-S45.
Web of Science
Kronberger, L; Wagner, P; Puchinger, M; Stranzl, H; Lax, SF; Kohek, P; Linck, FG; Schippinger, W; Thalhammer, M; Rigler, M; Hoess, G; Samonigg, H; Mischinger, HJ; Kapp, K; Rehak, P; Smola, M
Radiofrequency Hyperthermia in Combination with Chemo- and Radiotherapy in Palliative Treatment of Breast Cancer - A Case Report.
Proceedings of the 2nd Cancer Symposium, 25° Congresso Nazionale Società Italiana di Chirurgia Oncologica SICO - 2nd World Congress of WFSOS; Monduzzi Editore, Bologna, ITALY2002; -2nd Cancer Symposium, 25° Congresso Nazionale Società Italiana di Chirurgia Oncologica SICO - 2nd World Congress of WFSOS; Sept 19-21, 2001; Neapel, ITALIEN. (ISBN: 88-323-1920-9 )
[Oral Communication]
Ploner, F; Genser, B; Schippinger, W; Hofmann, G; Samonigg, H
The influence of prognostic factors seems to be constant throughout the course of metastatic breast cancer regardless of therapeutical intervention.
BREAST CANCER RES TREAT. 2002; 76: S48-S48.
Web of Science
Schippinger, W; Bauernhofer, T; Ploner, F; Hofmann, G; Krippl, P; Neumann, R; Wernecke, KD; Samonigg, H
Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
BREAST CANCER RES TREAT 2002 76: S104-S104.
Web of Science
Strobl, S; Verebes, J; Frohlich, B; Krenn, G; Baumgartner, J; Wernecke, KD; Samonigg, H
Prospective evaluation study of a hospital-based palliative care supportive service
J PALLIATIVE CARE 2002 18: 243-243.
Web of Science
Taucher, S; Gnant, M; Hausmaninger, H; Kubista, E; Samonigg, H; Steger, G; Stierer, M; Tausch, C; Jakesz, R
The prognostic influence of body mass index in premenopausal breast cancer patients.
BREAST CANCER RES TREAT 2002 76: S50-S50.
Web of Science
Andritsch, E; Baider, L; Samonigg, H; Uziely, B; Ever-Hadani, P; Hofmann, G; Goldzweig, G
Psychological distress in a sample of breast cancer women: a cross-cultural study between Graz and Jerusalem
PSYCHO-ONCOL 2001 10: B085-B085.
Web of Science
Kronberger, L; Wagner, P; Puchinger, M; Stranzl, H; Linck, G; Schippinger, W; Thalhammer, M; Rigler, M; Hoess, G; Samonigg, H; Mischinger, HJ; Kapp, K; Rehak, P; Smola, M; Kohek, P
Foudroyanter Verlauf eines Frührezidivs nach Mammakarzinom - Ein Fallbericht und Stellung der Hyperthermie in Kombination mit Chemo- (PCT) und Strahlentherapie.
Eur Surg2001; 33(175):366-106.-42. Tagung der Österreichischen Gesellschaft für Chirurgie; JUN 14-16, 2001; Graz, Austria.
[Oral Communication]
Kuss, I; Wagner, P; Genser, B; Stöger, H; Kasparek, AK; Samonigg, H
Low dose weekly anthracycline chemotherapy for breast cancer patients with bone marrow infiltration.
ANN ONCOL 2000 11: 38-38.
Web of Science
Samonigg,H; Ludwig,H; Hinterberger,W; Lutz,D; Greinix,HT; Nachbaur,D; Niederwieser,D; Gastl,G; Baumgartner,G; Hausmanninger,H; Linkesch,W; Pittermann-Höcker,E; Fridrik,M; Schuster,J;
High-dose chemotherapy and stem cell transplantation in patients with breast cancer: an analysis of the data reported to the Austrian stem cell transplantation registry(ASCTR).
Bone Marrow Transpl. 2000; 25: 325-325.- ; ; .
[Poster]
Andritsch, E; Samonigg, H
An integrated psychological care model on the grazer university oncology institution
PSYCHO-ONCOL 1999 8: 53-53.
Web of Science
Bauernhofer, T; Schmid, M; Resel, M; Gilli, R; Halwachs, G; Lanzer, G; Wilders-Truschnig, M; Samonigg, H
Detection of minimal residual disease in bone marrow (BM) peripheral blood (PB) and apheresis products (AP) in metastatic breast cancer patients receiving sequential dose intensive chemotherapy with PBPC support.
BONE MARROW TRANSPLANT 1999 23: S145-S145.
Web of Science
Bauernhofer, T; Schmid, M; Stoeger, H; Kasparek, AK; Ploner, F; Kuss, I; Gilli, R; Lanzer, H; Samonigg, H
Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
BONE MARROW TRANSPLANT 1999 23: S37-S37.
Web of Science
Jakesz, R; Hausmaninger, H; Samonigg, H; Kubista, E; Depisch, D; Fridrik, M; Stierer, M; Gnant, M; Steger, G; Kolb, R; Jatzko, G; Hofbauer, F; Reiner, G; Steindorfer, P
Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: Four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
EUR J CANCER. 1999; 35: S83-S83.
Doi: 10.1016/S0959-8049(99)80701-1
Web of Science
FullText
FullText_MUG
Samonigg, H; Kuss, I; Bauernhofer, T; Andritsch, E
The influence of an artistic design at an oncological ward on the patients' mood
PSYCHO-ONCOL 1999 8: 41-41.
Web of Science
Schmid, M; Bauernhofer, T; Resel, M; Ploner, F; Schippinger, W; Gilli, R; Lanzer, G; Truschnig-Wilders, M; Samonigg, H
High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
BONE MARROW TRANSPLANT 1999 23: S42-S42.
Web of Science
vonMinckwitz, G; Heidemann, E; Souchon, R; Samonigg, H; Hirschmann, WD; Bodenstein, H; Schindler, A; Schulze, M; Clemens, H; Konig, M; Scharl, A; Fischer, JT; Kaufmann, M
Mitoxantrone (N) vs. 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as first line therapy in high-risk metastatic breast cancer
EUR J CANCER 1997 33: 646-646.
Web of Science
Derstvenscheg, E; Stöger, H; Stranzl, H; Bauernhofer, T; Ploner, F; Samonigg, H
Das männl. Mammakarzinom- ein Bericht über 43 Patienten
Acta Chirurgica Austriaca, 28 (125), 1996, p 131996; 28(125):13-13.-Senologiekongress; 17.-19. Oktober 1996; Graz, Österreich.
[Poster]
LUDWIG, H; FRITZ, E; LEITGEB, C; PECHERSTORFER, M; SAMONIGG, H; SCHUSTER, J
ERYTHROPOIETIN FOR CHRONIC ANEMIA OF CANCER - TREATMENT RESULTS AND PREDICTION OF RESPONSIVENESS
EUR J CANCER 1995 31A: 7-7.
Web of Science
SAMONIGG, H; WILDERSTRUSCHNIG, M; KUSS, I; PLOT, R; STOGER, H; SCHMID, M; BAUERNHOFER, T; TIRAN, A; HAVELEC, L; LOIBNER, H
IMMUNIZATION WITH ANTIIDIOTYPE VACCINE SCV-106 PROLONGS SURVIVAL-TIME OF CANCER-PATIENTS WITH METASTATIC COLORECTAL-CANCER - A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL
EUR J CANCER 1995 31A: 45-45.
Web of Science
SAMONIGG, H; SCHEITHAUER, W; DEPISCH, D; WIEGELE, J; SCHULLER, J; HAUSMANNINGER, H; LUDWIG, H; STOGER, H; PREIS, P; KASPAREK, AK; ZIELINSKI, C
PHASE-II STUDY - PIRARUBICIN (4-O-TETRAHYDRO-PYRANYL-ADRIAMYCIN THP) IN ADVANCED BREAST-CANCER
BLUT. 1988; 57(4): 206-206.
Web of Science
Smola, M; Kotz, R; Ludwig, H; Dinstl, K; Salzer-Kuntschnik, M; Ritschl, P; Vinzen, K; Fellinger, E, Russe, W; Papp, Ch; Hawlicek, R; Samonigg, H; Depisch, D; Beham, A, Arian-Schad, K
Kooperative Weichteilsarkomstudie (CWSS).
Abstractband des ACO-Scherpunktsymposium1988; -ACO-Schwerpunktsymposium; SEP 30 - OKT 1, 1988; Pörtschach, AUSTRIA.
[Oral Communication]
STARK, G; STARK, U; SAMONIGG, H; KASPAREK, K; BERTUCH, H; HONIGL, K; PILGER, E; STOGER, H; TRITTHART, HA
THE INFLUENCE BY ADRIBLASTIN AND PIRARUBICIN ON CARDIAC ELECTRICAL-ACTIVITY
BLUT. 1988; 57(4): 202-202.
Web of Science
SAMONIGG, H; STOGER, H; KASPAREK, AK
A PHASE-II-STUDY - COMBINATION CHEMOTHERAPY FOR ADVANCED BREAST-CANCER WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE
BLUT. 1987; 55(4): 362-362.
Web of Science
STOGER, H; KASPAREK, AK; SAMONIGG, H
PREOPERATIVE POLYCHEMOTHERAPY WITH MITOXANTRONE, 5-FLUOROURACIL AND PREDNIMUSTINE FOR INFLAMMATORY BREAST-CANCER
BLUT. 1987; 55(4): 363-363.
Web of Science
SAMONIGG, H; LEB, G; SPEHN, J; HOSSFELD, D; FILL, H
METASTASIZING THYROID-CARCINOMA - THERAPY WITH ACLARUBICIN
ACTA MED AUST. 1986; 13: 96-97.
Web of Science
SAMONIGG, H; LEB, G; GOEBEL, R; BIFFL, E
THE VALUE OF LAMIN IN P-1 AS TUMOR-MARKERS IN METASTASIZING MAMMARY-CANCER
ACTA MED AUST. 1985; 12: 63-64.
Web of Science
FEREBERGER, W; SAMONIGG, H; MOROZ, C
FERRITIN-BEARING LYMPHOCYTES AS A DIAGNOSTIC-TOOL IN BREAST-CANCER PATIENTS
BLUT. 1984; 49(3): 261-262.
Web of Science
SAMONIGG, H; FEREBERGER, W; LEB, G; BIFFL, E
ACLACINOMYCIN THERAPY IN METASTASIZING THYROID-CANCER
BLUT. 1983; 47(3): 175-176.
Web of Science
SAMONIGG, H; LEB, G; GOEBEL, R; FEREBERGER, W; BIFFL, E
ACLACINOMYCIN-A, A NEW CYTOSTATIC AGENT IN THE TREATMENT OF THYROID-CARCINOMA
ACTA ENDOCRINOL. 1983; 102: 77-78.
Web of Science
FEREBERGER, W; SAMONIGG, H; NEUBAUER, M; BIFFL, E
ACLACINOMYCIN-A IN SOLID TUMORS - PRELIMINARY-RESULTS OF A PHASE-II TRIAL
BLUT. 1982; 45(3): 182-183.
Web of Science
FEREBERGER, W; LEB, G; PASSATH, A; SAMONIGG, H; BEAUFORT, F
SERUM CALCITONIN LEVEL IN CASES OF BREAST-CANCER
ACTA MED AUST. 1981; 8: 190-190.
Web of Science
SAMONIGG, H; FEREBERGER, W; LANZER, G; NEUBAUER, M
DIURNAL FLUCTUATIONS IN IMMUNOGLOBULINS AND PARAPROTEINS
ACTA MED AUST. 1981; 8: 198-198.
Web of Science
SAMONIGG, H; FEREBERGER, W; STEINDORFER, P
TREATMENT OF BREAST-CANCER IN MEN
ACTA MED AUST. 1981; 8: 198-198.
Web of Science
SOMMERSGUTTER, M; SAMONIGG, H; FEREBERGER, W; ZANGGER, J
THE INFLUENCE OF LOCAL APPLICATION OF 5-FLUOROURACIL ON THE NORMAL BRONCHIAL AND ALVEOLAR EPITHELIUM OF THE RAT
ACTA MED AUST. 1981; 8: 200-201.
Web of Science